Literature DB >> 15276427

The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.

Seishiro Hirano1, Yayoi Kobayashi, Xing Cui, Sanae Kanno, Toru Hayakawa, Amjad Shraim.   

Abstract

Excess intake of arsenic is known to cause vascular diseases as well as skin lesions and cancer in humans. Recent reports suggest that trivalent methylated arsenicals, which are intermediate metabolites in the methylation process of inorganic arsenic, are responsible for the toxicity and carcinogenicity of environmental arsenic. We investigated acute toxicity and accumulation of monomethylarsonic acid (MMA(V)), dimethylarsinic acid (DMA(V)), trimethylarsine oxide (TMAO), and monomethylarsonous acid diglutathione (MMA(III) (GS)(2)) in rat heart microvessel endothelial (RHMVE) cells. MMA(V) (LC(50) = 36.6 mM) and DMA(V) (LC(50) = 2.54 mM) were less toxic than inorganic arsenicals (cf. LC(50) values for inorganic arsenite (iAs(III)), and inorganic arsenate (iAs(V)) was reported to be 36 and 220 microM, respectively, in RHMVE cells. TMAO was essentially not toxic. However, MMA(III) (GS)(2) was highly toxic (LC(50) = 4.1 microM). The order of cellular arsenic accumulation of those four organic arsenic compounds was MMA(III) (GS)(2) >> MMA(V) > DMA(V) > TMAO. MMA(III) (GS)(2) was efficiently taken up by the cells and cellular arsenic content increased with the concentration of MMA(III) (GS)(2) in culture medium. N-acetyl-l-cysteine (NAC) reduced cellular arsenic content in DMA(V)-exposed cells and also decreased the cytotoxicity of DMA(V), whereas it changed neither cellular arsenic content nor the viability in MMA(V)-exposed cells. mRNA levels of heme oxygenase-1 (HO-1) were decreased by NAC in DMA(V)-exposed, but MMA(V)-exposed cells. Buthionine sulfoximine (BSO), a cellular glutathione (GSH) depleting agent, enhanced the cytotoxicity of MMA(V). However, BSO reduced, rather than enhanced, the cytotoxicity of DMA(V). These results suggest that intracellular GSH modulated the toxic effects of arsenic in opposite ways for MMA(V) and DMA(V). Even though intracellular GSH decreased the cytotoxicity of MMA(V), extracellularly added GSH enhanced the cytotoxicity of MMA(V). The use of high-performance liquid chromatography (HPLC)-inductively coupled plasma mass spectrometric analyses suggested that a small amount of MMA(V) was converted to MMA(III) (GS)(2) in the presence of GSH. These results suggest that MMA(III) (GS)(2) is highly toxic compared to other arsenic compounds because of faster accumulation of this species by cells, in addition to having the toxic nature of methylated trivalent organic arsenics.

Entities:  

Mesh:

Year:  2004        PMID: 15276427     DOI: 10.1016/j.taap.2003.10.023

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  39 in total

1.  Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.

Authors:  Sabyasachi Biswas; Xiaobin Zhao; Andrew P Mone; Xiaokui Mo; Melissa Vargo; David Jarjoura; John C Byrd; Natarajan Muthusamy
Journal:  Leuk Res       Date:  2010-02-19       Impact factor: 3.156

2.  Glutathione S-transferase M1 and GST T1 genetic polymorphisms and Raynaud's phenomenon in French vinyl chloride monomer-exposed workers.

Authors:  Luc Fontana; Marie-Jeanne Marion; Sylvie Ughetto; Pierre Catilina
Journal:  J Hum Genet       Date:  2006-09-15       Impact factor: 3.172

Review 3.  Double-Sided Personality: Effects of Arsenic Trioxide on Inflammation.

Authors:  Juan Zhang; Yue Zhang; Weiyan Wang; Chunling Li; Zhiyi Zhang
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

4.  Bioaccumulation and biotransformation of arsenic compounds in Hediste diversicolor (Muller 1776) after exposure to spiked sediments.

Authors:  Andrea Gaion; Davide Sartori; Alice Scuderi; Daniele Fattorini
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-24       Impact factor: 4.223

Review 5.  Individual susceptibility to arsenic-induced diseases: the role of host genetics, nutritional status, and the gut microbiome.

Authors:  Liang Chi; Bei Gao; Pengcheng Tu; Chih-Wei Liu; Jingchuan Xue; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Mamm Genome       Date:  2018-02-10       Impact factor: 2.957

6.  Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice.

Authors:  Erik J Tokar; Bhalchandra A Diwan; David J Thomas; Michael P Waalkes
Journal:  Arch Toxicol       Date:  2012-03-08       Impact factor: 5.153

7.  Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.

Authors:  Erika B Dugo; Clement G Yedjou; Jacqueline J Stevens; Paul B Tchounwou
Journal:  Ann Clin Pathol       Date:  2017-01-04

Review 8.  Arsenic trioxide: insights into its evolution to an anticancer agent.

Authors:  Maneka Hoonjan; Vaibhav Jadhav; Purvi Bhatt
Journal:  J Biol Inorg Chem       Date:  2018-02-02       Impact factor: 3.358

9.  Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice.

Authors:  Liang Chi; Jingchuan Xue; Pengcheng Tu; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Arch Toxicol       Date:  2018-10-24       Impact factor: 5.153

Review 10.  The case for visual analytics of arsenic concentrations in foods.

Authors:  Matilda O Johnson; Hari H P Cohly; Raphael D Isokpehi; Omotayo R Awofolu
Journal:  Int J Environ Res Public Health       Date:  2010-04-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.